177 related articles for article (PubMed ID: 22906998)
1. Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma.
Jang JW; Oh BS; Kwon JH; You CR; Chung KW; Kay CS; Jung HS
Cytokine; 2012 Dec; 60(3):686-93. PubMed ID: 22906998
[TBL] [Abstract][Full Text] [Related]
2. The analysis of the usefulness of laparoscopic microwave coagulation therapy for hepatocellular carcinoma in patients with poor hepatic reserve by serial measurements of IL-6, cytokine antagonists, and C-reactive protein.
Sadamori H; Yagi T; Kanaoka Y; Morimoto Y; Inagaki M; Ishikawa T; Matsukawa H; Matsuda H; Iwagaki H; Tanaka N
Surg Endosc; 2003 Mar; 17(3):510-4. PubMed ID: 12399851
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
[TBL] [Abstract][Full Text] [Related]
4. Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma.
Kim MJ; Jang JW; Oh BS; Kwon JH; Chung KW; Jung HS; Jekarl DW; Lee S
Cytokine; 2013 Nov; 64(2):516-22. PubMed ID: 24035756
[TBL] [Abstract][Full Text] [Related]
5. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M
Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
[TBL] [Abstract][Full Text] [Related]
6. Preoperative levels of serum interleukin-6 in patients with hepatocellular carcinoma.
Pang XH; Zhang JP; Zhang YJ; Yan J; Pei XQ; Zhang YQ; Li JQ; Zheng L; Chen MS
Hepatogastroenterology; 2011; 58(110-111):1687-93. PubMed ID: 21940335
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
Parasole R; Izzo F; Perrone F; Pignata S; Galati MG; Leonardi E; Castiglione F; Orlando R; Castello G; Esposito G; Gallo C; Daniele B
Clin Cancer Res; 2001 Nov; 7(11):3504-9. PubMed ID: 11705869
[TBL] [Abstract][Full Text] [Related]
8. Postoperative peak serum C-reactive protein predicts outcome of hepatic resection for hepatocellular carcinoma.
Shiba H; Furukawa K; Fujiwara Y; Futagawa Y; Haruki K; Wakiyama S; Ishida Y; Misawa T; Yanaga K
Anticancer Res; 2013 Feb; 33(2):705-9. PubMed ID: 23393371
[TBL] [Abstract][Full Text] [Related]
9. IL-18 and interferon-gamma in HCV-related hepatocellular carcinoma: a model of interplay between immune status and cancer.
Perrella O; Cuomo O; Sbreglia C; Monaco A; Gnarini MR; Gentile B; Perrella M; Perrella A
J Biol Regul Homeost Agents; 2009; 23(4):251-8. PubMed ID: 20003764
[TBL] [Abstract][Full Text] [Related]
10. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.
Hashimoto K; Ikeda Y; Korenaga D; Tanoue K; Hamatake M; Kawasaki K; Yamaoka T; Iwatani Y; Akazawa K; Takenaka K
Cancer; 2005 May; 103(9):1856-64. PubMed ID: 15779015
[TBL] [Abstract][Full Text] [Related]
11. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC
Hepatogastroenterology; 2009; 56(93):1105-10. PubMed ID: 19760951
[TBL] [Abstract][Full Text] [Related]
12. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
Kitaoka S; Shiota G; Kawasaki H
Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.
Lin CY; Kuo CS; Lu CL; Wu MY; Huang RF
Nutr Cancer; 2010; 62(2):190-7. PubMed ID: 20099193
[TBL] [Abstract][Full Text] [Related]
15. A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma.
Chan SL; Mo FK; Wong CS; Chan CM; Leung LK; Hui EP; Ma BB; Chan AT; Mok TS; Yeo W
Cancer; 2012 Aug; 118(16):3984-92. PubMed ID: 22180222
[TBL] [Abstract][Full Text] [Related]
16. Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma.
Sieghart W; Pinter M; Hucke F; Graziadei I; Schöniger-Hekele M; Müller C; Vogel W; Trauner M; Peck-Radosavljevic M
Hepatology; 2013 Jun; 57(6):2224-34. PubMed ID: 22961713
[TBL] [Abstract][Full Text] [Related]
17. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis.
Ren Y; Poon RT; Tsui HT; Chen WH; Li Z; Lau C; Yu WC; Fan ST
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5996-6001. PubMed ID: 14676125
[TBL] [Abstract][Full Text] [Related]
19. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum IL-8 is associated with the presence of hepatocellular carcinoma and independently predicts survival.
Welling TH; Fu S; Wan S; Zou W; Marrero JA
Cancer Invest; 2012 Dec; 30(10):689-97. PubMed ID: 23072563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
